Literature DB >> 2279701

Dominant-negative mutants of a platelet-derived growth factor gene.

M Mercola1, P L Deininger, S M Shamah, J Porter, C Y Wang, C D Stiles.   

Abstract

Using site-directed mutagenesis of a PDGF-A cDNA clone, we identify two domains that are required to generate stable, mitogenically active PDGF-AA homodimers. Alteration of the tetra-basic amino acid sequence (Arg84-Arg-Lys-Arg to Arg-Ser-Asn-Gly) results in the formation of stable pro-PDGF-A homodimers that lack mitogenic activity. Substitution of serine for Cys129 destabilizes PDGF-A subunits within the cell. Genes incorporating either the processing lesion or the cysteine substitution suppress wild-type PDGF-A gene expression in a trans-dominant fashion. Suppression occurs because the mutant PDGF subunits dimerize with wild-type subunits to form inactive or unstable heterodimers. Suppression is exerted across phylogenetic boundaries; thus, the mouse PDGF-A chain mutants inhibit the activity of the wild-type Xenopus PDGF-A. The cysteine mutant gene suppresses expression of PDGF-B (c-sis), as well as PDGF-A. The processing mutant gene, however, suppresses only PDGF-A. Dominant-negative mutations of PDGF and other growth factors which, like PDGF, function as dimers may prove useful for creating animals models of growth factor deficiency disease states and for revealing the function of growth factors during early embryonic development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2279701     DOI: 10.1101/gad.4.12b.2333

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  17 in total

1.  Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity.

Authors:  Z Zhu; C S Lee; K M Tejeda; W V Giannobile
Journal:  J Dent Res       Date:  2001-03       Impact factor: 6.116

2.  Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors.

Authors:  Qiming Jin; Orasa Anusaksathien; Sarah A Webb; Marie A Printz; William V Giannobile
Journal:  Mol Ther       Date:  2004-04       Impact factor: 11.454

3.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

Review 4.  Platelet-derived growth factor in human brain tumors.

Authors:  M Kirsch; J C Wilson; P Black
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 5.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  The small co-chaperone p23 overexpressing transgenic mouse.

Authors:  Junli Zhang; Patricia Spilman; Sylvia Chen; Olivia Gorostiza; Alex Matalis; Kayvan Niazi; Dale E Bredesen; Rammohan V Rao
Journal:  J Neurosci Methods       Date:  2012-09-27       Impact factor: 2.390

7.  PDGF mediates cardiac microvascular communication.

Authors:  J M Edelberg; W C Aird; W Wu; H Rayburn; W S Mamuya; M Mercola; R D Rosenberg
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum.

Authors:  Orasa Anusaksathien; Qiming Jin; Ming Zhao; Martha J Somerman; William V Giannobile
Journal:  J Periodontol       Date:  2004-03       Impact factor: 6.993

9.  Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms.

Authors:  A R Lopez; J Cook; P L Deininger; R Derynck
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant.

Authors:  F S Vassbotn; M Andersson; B Westermark; C H Heldin; A Ostman
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.